- Home
- ALBT vs CHNR Comparison
ALBT vs CHNR Comparison
Compare ALBT & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- CHNR
- Stock Information
- Founded
- ALBT 2014
- CHNR N/A
- Country
- ALBT United States
- CHNR Hong Kong
- Employees
- ALBT N/A
- CHNR N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- CHNR Precious Metals
- Sector
- ALBT Health Care
- CHNR Basic Materials
- Exchange
- ALBT Nasdaq
- CHNR Nasdaq
- Market Cap
- ALBT 2.9M
- CHNR 6.4M
- IPO Year
- ALBT N/A
- CHNR 1995
- Fundamental
- Price
- ALBT $0.20
- CHNR $0.79
- Analyst Decision
- ALBT
- CHNR
- Analyst Count
- ALBT 0
- CHNR 0
- Target Price
- ALBT N/A
- CHNR N/A
- AVG Volume (30 Days)
- ALBT 633.7K
- CHNR 148.0K
- Earning Date
- ALBT 11-12-2024
- CHNR 01-01-0001
- Dividend Yield
- ALBT N/A
- CHNR N/A
- EPS Growth
- ALBT N/A
- CHNR N/A
- EPS
- ALBT N/A
- CHNR N/A
- Revenue
- ALBT N/A
- CHNR N/A
- Revenue This Year
- ALBT N/A
- CHNR N/A
- Revenue Next Year
- ALBT N/A
- CHNR N/A
- P/E Ratio
- ALBT N/A
- CHNR N/A
- Revenue Growth
- ALBT N/A
- CHNR N/A
- 52 Week Low
- ALBT $0.16
- CHNR $0.55
- 52 Week High
- ALBT $1.44
- CHNR $8.85
- Technical
- Relative Strength Index (RSI)
- ALBT 43.14
- CHNR 53.35
- Support Level
- ALBT $0.16
- CHNR $0.68
- Resistance Level
- ALBT $0.22
- CHNR $0.83
- Average True Range (ATR)
- ALBT 0.03
- CHNR 0.10
- MACD
- ALBT 0.00
- CHNR -0.00
- Stochastic Oscillator
- ALBT 27.54
- CHNR 24.60
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.